Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00207649 · ClinicalTrials.gov registry record · NA

Shared Decision Making: Prostate Cancer Screening

A NA study of Prostate Cancer, sponsored by Lisa Richarson.

Completed
Registry status
NA
Development phase
641
Enrollment target
1
Study location

NCT00207649: Completed NA study of Prostate Cancer, sponsored by Lisa Richarson.

NCT00207649 is a NA study of Prostate Cancer that has completed, run by Lisa Richarson. The registered enrollment target is 641 participants, roughly in line with the 607-participant average among 735 other Prostate Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00207649, a NA study of Prostate Cancer, has completed, sponsored by Lisa Richarson.

COMPLETED
Registry status
NA
Development phase
641 participants
Enrollment target
1
Study location

Study Summary

Interventions to Improve Shared Decision-Making: Prostate Cancer Screening is a prospective study of educational interventions to improve the interaction of physicians and their patients about prostate cancer screening. Educational material is provided in primary care practices using either standard paper information or a novel web-based interactive curriculum that explores the risks and benefits of screening measures for prostate cancer for older men. The impact of the intervention on shared decision-making with both actual and standardized patients will be assessed.

Conditions Studied

Interventions

  • BEHAVIORAL Shared decision-making for PSA screening tool

Study Locations (1)

California

  • University of California Davis, Center for Health Services Research - Sacramento

Trial Details

FieldValue
Enrollment Target 641 participants
Start Date 2005-11
Est. Completion 2011-02
Phase NA
Lisa Richarson

1 total trials

What the finished NCT00207649 record still lists

NCT00207649 is an interventional study that assigns participants to a tested intervention. The registered 641 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 607-participant average among 735 other Prostate Cancer trials with a reported enrollment target.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Shared decision-making for PSA screening tool is the first listed.

NCT00207649 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00207649 about?

NCT00207649 is a clinical study titled "Shared Decision Making: Prostate Cancer Screening". Interventions to Improve Shared Decision-Making: Prostate Cancer Screening is a prospective study of educational interventions to improve the interaction of physicians and their patients about prostate cancer screening. Educational material is provided in primary care practices using either standard...

What is the current status of trial NCT00207649?

This trial is currently completed. It is a NA study. The enrollment target is 641 participants. The study started on 2005-11. Estimated completion is 2011-02.

What conditions does trial NCT00207649 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT00207649?

The interventions under investigation include: Shared decision-making for PSA screening tool (BEHAVIORAL).

Who is sponsoring clinical trial NCT00207649?

This trial is sponsored by Lisa Richarson, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00207649 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00207649's enrollment target sits among peer trials

641 93rd of 735 higher than 643 of 735 other Prostate Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06319820 · 641 participants · Phase 3

    A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

  • NCT06625060 · 641 participants · Phase 2

    A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

  • NCT05204888 · 642 participants · NA

    myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

  • NCT04339699 · 640 participants · NA

    NobleStitch EL STITCH Trial is a PFO Comparative Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00207649, the US trial registry maintained by the National Library of Medicine. NCT00207649 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.